Home › Free Stock Grades › WVE
Wave Life Sciences Ltd. (WVE) Stock Grade
WVE · Healthcare
C
Market Cap
$723.2M
P/E Ratio
—
Revenue Growth (YoY)
-60.6%
Net Margin
-478.3%
Return on Equity
—
Dividend Yield
None
About Wave Life Sciences Ltd.'s fundamentals
Wave Life Sciences is a biotechnology company with a market capitalization of $723.2 million that is currently unprofitable, reporting a net loss in its latest annual statement and a net margin of -478.3%. The company experienced significant revenue decline, with year-over-year revenue falling 60.6%, indicating substantial contraction in its business. The company does not pay a dividend, and standard profitability metrics like price-to-earnings and return on equity are not applicable due to its loss-making status.